Artificial intelligence in clinical research: Accelerating drug discovery and development

This review article examines the use of AI (Artificial Intelligence) in clinical research and its implications for the pharmaceutical industry. The article discusses the potential benefits of AI for drug discovery, patient selection, and monitoring, as well as the ethical and regulatory considerations associated with these technologies. The implications of AI for the pharmaceutical industry are significant, with the potential to reduce costs and improve patient outcomes. However, it is important to address the ethical and regulatory considerations associated with the use of AI in clinical research to ensure that these technologies are developed and implemented in a responsible and ethical manner. Overall, the article highlights the potential of AI to transform the pharmaceutical industry and the need for ongoing dialogue and collaboration to ensure its responsible and ethical use.